Header Logo

Connection

WOLFGANG WINKELMAYER to Aged

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Aged.
WOLFGANG WINKELMAYER
Connection Strength
4.002
Aged
  1. A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 07; 106(1):145-153.
    View in: PubMed
    Score: 0.066
  2. The Association of Pre-Kidney Transplant Dialysis Modality with de novo Posttransplant Heart Failure. Cardiorenal Med. 2021; 11(5-6):209-217.
    View in: PubMed
    Score: 0.056
  3. Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates. J Am Soc Nephrol. 2021 06 01; 32(6):1319-1321.
    View in: PubMed
    Score: 0.054
  4. Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018. PLoS One. 2020; 15(12):e0243431.
    View in: PubMed
    Score: 0.053
  5. Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health. Clin J Am Soc Nephrol. 2020 07 01; 15(7):937-948.
    View in: PubMed
    Score: 0.051
  6. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. J Am Soc Nephrol. 2020 06; 31(6):1325-1334.
    View in: PubMed
    Score: 0.051
  7. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360.
    View in: PubMed
    Score: 0.049
  8. Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis. Clin J Am Soc Nephrol. 2019 07 05; 14(7):1029-1038.
    View in: PubMed
    Score: 0.048
  9. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331.
    View in: PubMed
    Score: 0.046
  10. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.046
  11. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541.
    View in: PubMed
    Score: 0.045
  12. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597.
    View in: PubMed
    Score: 0.045
  13. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States. Transplantation. 2017 10; 101(10):2636-2647.
    View in: PubMed
    Score: 0.042
  14. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study. BMC Nephrol. 2017 Jun 17; 18(1):196.
    View in: PubMed
    Score: 0.041
  15. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus. J Am Heart Assoc. 2017 Jun 07; 6(6).
    View in: PubMed
    Score: 0.041
  16. Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis. Nephrol Dial Transplant. 2017 May 01; 32(5):862-869.
    View in: PubMed
    Score: 0.041
  17. Nephrologists' Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):454-466.
    View in: PubMed
    Score: 0.041
  18. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. Am J Kidney Dis. 2017 Jun; 69(6):771-779.
    View in: PubMed
    Score: 0.040
  19. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol. 2017 Apr; 30(2):281-288.
    View in: PubMed
    Score: 0.039
  20. Kidney Transplantation Outcomes across GN Subtypes in the United States. J Am Soc Nephrol. 2017 02; 28(2):632-644.
    View in: PubMed
    Score: 0.039
  21. Predicting mortality over different time horizons: which data elements are needed? J Am Med Inform Assoc. 2017 01; 24(1):176-181.
    View in: PubMed
    Score: 0.039
  22. Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data. BMC Nephrol. 2016 Feb 09; 17:16.
    View in: PubMed
    Score: 0.038
  23. Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease. BMC Nephrol. 2015 Dec 09; 16:204.
    View in: PubMed
    Score: 0.037
  24. Coffee and caffeine consumption and the risk of hypertension in postmenopausal women. Am J Clin Nutr. 2016 Jan; 103(1):210-7.
    View in: PubMed
    Score: 0.037
  25. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA. Nephrol Dial Transplant. 2016 Feb; 31(2):290-8.
    View in: PubMed
    Score: 0.037
  26. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. Nephrol Dial Transplant. 2015 Dec; 30(12):2068-75.
    View in: PubMed
    Score: 0.037
  27. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Am J Kidney Dis. 2015 Oct; 66(4):677-88.
    View in: PubMed
    Score: 0.036
  28. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
    View in: PubMed
    Score: 0.036
  29. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Am J Kidney Dis. 2015 Jul; 66(1):106-13.
    View in: PubMed
    Score: 0.036
  30. Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States. Am J Transplant. 2015 Feb; 15(2):499-507.
    View in: PubMed
    Score: 0.035
  31. Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation. Nephrol Dial Transplant. 2015 Feb; 30(2):321-9.
    View in: PubMed
    Score: 0.035
  32. Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
    View in: PubMed
    Score: 0.035
  33. Heparin use in hemodialysis patients following gastrointestinal bleeding. Am J Nephrol. 2014; 40(4):300-7.
    View in: PubMed
    Score: 0.034
  34. Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med. 2014 May; 174(5):699-707.
    View in: PubMed
    Score: 0.033
  35. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr; 14(4):943-951.
    View in: PubMed
    Score: 0.033
  36. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
    View in: PubMed
    Score: 0.033
  37. Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant. 2013 Jun; 13(6):1566-75.
    View in: PubMed
    Score: 0.031
  38. Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1336-42.
    View in: PubMed
    Score: 0.031
  39. Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. Am J Kidney Dis. 2013 Aug; 62(2):312-21.
    View in: PubMed
    Score: 0.031
  40. Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol. 2013 Apr 26; 14:97.
    View in: PubMed
    Score: 0.031
  41. Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrol Dial Transplant. 2013 Jun; 28(6):1589-602.
    View in: PubMed
    Score: 0.031
  42. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg. 2013 Jan; 95(1):20-8.
    View in: PubMed
    Score: 0.030
  43. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol. 2012 Dec; 23(12):2042-9.
    View in: PubMed
    Score: 0.030
  44. Predialyis nephrology care of older individuals approaching end-stage renal disease. Semin Dial. 2012 Nov-Dec; 25(6):628-32.
    View in: PubMed
    Score: 0.030
  45. Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013 Mar-Apr; 33(2):155-66.
    View in: PubMed
    Score: 0.030
  46. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 06; 126(19):2293-301.
    View in: PubMed
    Score: 0.030
  47. Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
    View in: PubMed
    Score: 0.029
  48. Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol. 2012 Jun; 23(6):1078-85.
    View in: PubMed
    Score: 0.029
  49. Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005). J Nephrol. 2013 Mar-Apr; 26(2):281-8.
    View in: PubMed
    Score: 0.029
  50. Use of secondary prevention medications among adults with reduced kidney function. Clin J Am Soc Nephrol. 2012 Apr; 7(4):604-11.
    View in: PubMed
    Score: 0.029
  51. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol. 2012 Mar; 23(3):495-506.
    View in: PubMed
    Score: 0.029
  52. Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol. 2012 Feb; 7(2):289-96.
    View in: PubMed
    Score: 0.028
  53. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2662-8.
    View in: PubMed
    Score: 0.028
  54. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011 Aug 08; 171(15):1371-8.
    View in: PubMed
    Score: 0.028
  55. Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J. 2011 Aug; 162(2):324-30.
    View in: PubMed
    Score: 0.028
  56. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011 Sep; 58(3):409-17.
    View in: PubMed
    Score: 0.027
  57. The effect of altitude change on anemia treatment response in hemodialysis patients. Am J Epidemiol. 2011 Apr 01; 173(7):768-77.
    View in: PubMed
    Score: 0.027
  58. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011 Feb; 22(2):349-57.
    View in: PubMed
    Score: 0.027
  59. Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol. 2011 Apr; 6(4):864-9.
    View in: PubMed
    Score: 0.027
  60. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):57-65.
    View in: PubMed
    Score: 0.026
  61. Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clin J Am Soc Nephrol. 2011 Jan; 6(1):175-83.
    View in: PubMed
    Score: 0.026
  62. Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure. Clin Pharmacol Ther. 2010 Oct; 88(4):548-54.
    View in: PubMed
    Score: 0.026
  63. Medication issues in older individuals with CKD. Adv Chronic Kidney Dis. 2010 Jul; 17(4):320-8.
    View in: PubMed
    Score: 0.026
  64. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010 Mar 03; 303(9):857-64.
    View in: PubMed
    Score: 0.025
  65. ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized? Drugs Aging. 2010 Feb 01; 27(2):87-94.
    View in: PubMed
    Score: 0.025
  66. Impact of reimbursement changes on statin use among patients with diabetes in Austria. Wien Klin Wochenschr. 2010 Feb; 122(3-4):89-94.
    View in: PubMed
    Score: 0.025
  67. Lessons from geographic variations in predialysis nephrology care. J Am Soc Nephrol. 2009 May; 20(5):930-2.
    View in: PubMed
    Score: 0.024
  68. Altitude and all-cause mortality in incident dialysis patients. JAMA. 2009 Feb 04; 301(5):508-12.
    View in: PubMed
    Score: 0.023
  69. Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury. Am J Med. 2008 Dec; 121(12):1092-8.
    View in: PubMed
    Score: 0.023
  70. Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy. Arch Intern Med. 2008 Nov 24; 168(21):2368-75.
    View in: PubMed
    Score: 0.023
  71. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
    View in: PubMed
    Score: 0.022
  72. The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol. 2008 Jul; 19(7):1389-95.
    View in: PubMed
    Score: 0.022
  73. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
    View in: PubMed
    Score: 0.022
  74. Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age. Am J Cardiol. 2008 Jun 01; 101(11):1531-6.
    View in: PubMed
    Score: 0.022
  75. Use of recommended medications after myocardial infarction in Austria. Eur J Epidemiol. 2008; 23(2):153-62.
    View in: PubMed
    Score: 0.021
  76. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors. Int J Cardiol. 2008 Apr 10; 125(2):172-7.
    View in: PubMed
    Score: 0.021
  77. Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney Int. 2007 Dec; 72(11):1388-93.
    View in: PubMed
    Score: 0.021
  78. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7.
    View in: PubMed
    Score: 0.021
  79. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007 Jun; 20(6):505-11.
    View in: PubMed
    Score: 0.020
  80. Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease. Kidney Int. 2007 May; 71(9):938-45.
    View in: PubMed
    Score: 0.020
  81. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007 Aug; 93(8):945-51.
    View in: PubMed
    Score: 0.020
  82. Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7.
    View in: PubMed
    Score: 0.020
  83. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007 Jan; 71(2):153-8.
    View in: PubMed
    Score: 0.020
  84. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Diabetes Care. 2006 Oct; 29(10):2210-7.
    View in: PubMed
    Score: 0.020
  85. Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol. 2006 Jul; 1(4):796-801.
    View in: PubMed
    Score: 0.019
  86. Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making. 2006 May-Jun; 26(3):247-54.
    View in: PubMed
    Score: 0.019
  87. Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol. 2006 May; 1(3):455-61.
    View in: PubMed
    Score: 0.019
  88. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8.
    View in: PubMed
    Score: 0.019
  89. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
    View in: PubMed
    Score: 0.019
  90. Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int. 2005 Dec; 68(6):2857-62.
    View in: PubMed
    Score: 0.019
  91. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32.
    View in: PubMed
    Score: 0.018
  92. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int. 2005 May; 67(5):1980-5.
    View in: PubMed
    Score: 0.018
  93. Effects of dialysate potassium concentration of 3.0?mmol/l with sodium zirconium cyclosilicate on?dialysis-free days versus dialysate potassium?concentration of 2.0 mmol/l alone on?rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int. 2025 Jan; 107(1):169-179.
    View in: PubMed
    Score: 0.017
  94. Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb; 85(2):226-235.e1.
    View in: PubMed
    Score: 0.017
  95. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant. 2004 Jul; 4(7):1148-54.
    View in: PubMed
    Score: 0.017
  96. Effects of TCN2 776C>G on vitamin B, folate, and total homocysteine levels in kidney transplant patients. Kidney Int. 2004 May; 65(5):1877-81.
    View in: PubMed
    Score: 0.017
  97. Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol. 2004 Apr; 15(4):1052-60.
    View in: PubMed
    Score: 0.017
  98. Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis. JAMA Netw Open. 2024 04 01; 7(4):e248732.
    View in: PubMed
    Score: 0.017
  99. Hetastarch and bleeding complications after coronary artery surgery. Chest. 2003 Oct; 124(4):1437-42.
    View in: PubMed
    Score: 0.016
  100. Market Competition and Anemia Management in the United States Following Dialysis Payment Reform. Med Care. 2023 Nov 01; 61(11):787-795.
    View in: PubMed
    Score: 0.016
  101. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
    View in: PubMed
    Score: 0.016
  102. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003 May; 63(5):1836-42.
    View in: PubMed
    Score: 0.016
  103. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003 Feb; 14(2):486-92.
    View in: PubMed
    Score: 0.015
  104. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. Am J Kidney Dis. 2003 Jan; 41(1):84-9.
    View in: PubMed
    Score: 0.015
  105. Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. JAMA. 2022 11 08; 328(18):1837-1848.
    View in: PubMed
    Score: 0.015
  106. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62.
    View in: PubMed
    Score: 0.015
  107. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.015
  108. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
    View in: PubMed
    Score: 0.015
  109. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001 Dec; 38(6):1178-84.
    View in: PubMed
    Score: 0.014
  110. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
    View in: PubMed
    Score: 0.014
  111. Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
    View in: PubMed
    Score: 0.014
  112. Long-Term Exposures to Air Pollution and the Risk of Atrial Fibrillation in the Women's Health Initiative Cohort. Environ Health Perspect. 2021 09; 129(9):97007.
    View in: PubMed
    Score: 0.014
  113. Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
    View in: PubMed
    Score: 0.014
  114. Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. N Engl J Med. 2021 04 29; 384(17):1589-1600.
    View in: PubMed
    Score: 0.014
  115. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. N Engl J Med. 2021 04 29; 384(17):1601-1612.
    View in: PubMed
    Score: 0.014
  116. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1.
    View in: PubMed
    Score: 0.014
  117. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959.
    View in: PubMed
    Score: 0.013
  118. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 01 01; 36(1):129-136.
    View in: PubMed
    Score: 0.013
  119. Intradialytic Hypotension and Newly Recognized Peripheral Artery Disease in Patients Receiving Hemodialysis. Am J Kidney Dis. 2021 05; 77(5):730-738.
    View in: PubMed
    Score: 0.013
  120. Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics. Am Heart J. 2021 05; 235:1-11.
    View in: PubMed
    Score: 0.013
  121. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769.
    View in: PubMed
    Score: 0.013
  122. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
    View in: PubMed
    Score: 0.013
  123. Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study. Am J Kidney Dis. 2020 11; 76(5):679-689.
    View in: PubMed
    Score: 0.013
  124. Re-estimation improved the performance of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis. Sci Rep. 2020 05 18; 10(1):8140.
    View in: PubMed
    Score: 0.013
  125. Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study. Sci Rep. 2020 04 06; 10(1):5964.
    View in: PubMed
    Score: 0.013
  126. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.012
  127. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
    View in: PubMed
    Score: 0.012
  128. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
    View in: PubMed
    Score: 0.012
  129. Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
    View in: PubMed
    Score: 0.012
  130. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. J Diabetes Complications. 2019 11; 33(11):107423.
    View in: PubMed
    Score: 0.012
  131. A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes. PLoS One. 2019; 14(7):e0218709.
    View in: PubMed
    Score: 0.012
  132. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
    View in: PubMed
    Score: 0.012
  133. Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA Netw Open. 2019 05 03; 2(5):e193987.
    View in: PubMed
    Score: 0.012
  134. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
    View in: PubMed
    Score: 0.011
  135. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.011
  136. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis. Int J Cardiol. 2019 05 15; 283:165-170.
    View in: PubMed
    Score: 0.011
  137. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 10 01; 178(10):1358-1367.
    View in: PubMed
    Score: 0.011
  138. The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1517-1525.
    View in: PubMed
    Score: 0.011
  139. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
    View in: PubMed
    Score: 0.011
  140. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.011
  141. Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant. 2018 07 01; 33(7):1207-1214.
    View in: PubMed
    Score: 0.011
  142. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
    View in: PubMed
    Score: 0.011
  143. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
    View in: PubMed
    Score: 0.011
  144. Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1778-1786.
    View in: PubMed
    Score: 0.010
  145. Hospitalizations and Nursing Facility Stays During the Transition from CKD to ESRD on Dialysis: An Observational Study. J Gen Intern Med. 2017 Nov; 32(11):1220-1227.
    View in: PubMed
    Score: 0.010
  146. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281.
    View in: PubMed
    Score: 0.010
  147. Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation. 2017 Apr; 101(4):851-857.
    View in: PubMed
    Score: 0.010
  148. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis. 2017 Oct; 70(4):464-475.
    View in: PubMed
    Score: 0.010
  149. Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
    View in: PubMed
    Score: 0.010
  150. Warfarin Initiation, Atrial Fibrillation, and Kidney Function:?Comparative Effectiveness and Safety of?Warfarin?in?Older?Adults?With Newly Diagnosed Atrial?Fibrillation. Am J Kidney Dis. 2017 Jun; 69(6):734-743.
    View in: PubMed
    Score: 0.010
  151. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. J Cardiovasc Electrophysiol. 2017 01; 28(1):39-48.
    View in: PubMed
    Score: 0.010
  152. Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease. Heart. 2017 06; 103(11):818-826.
    View in: PubMed
    Score: 0.010
  153. The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients. Clin Lab. 2016 Oct 01; 62(10):1965-1972.
    View in: PubMed
    Score: 0.010
  154. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1401-1412.
    View in: PubMed
    Score: 0.010
  155. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21.
    View in: PubMed
    Score: 0.010
  156. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. Am J Kidney Dis. 2016 Sep; 68(3):444-54.
    View in: PubMed
    Score: 0.009
  157. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant. 2016 05; 16(5):1492-502.
    View in: PubMed
    Score: 0.009
  158. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related?Quality of Life in Patients Receiving?Hemodialysis. Am J Kidney Dis. 2016 Feb; 67(2):271-82.
    View in: PubMed
    Score: 0.009
  159. Menopausal symptoms in women with chronic kidney disease. Menopause. 2015 Sep; 22(9):1006-11.
    View in: PubMed
    Score: 0.009
  160. Kidney Function and Cardiovascular Events in Postmenopausal Women: The Impact of Race and Ethnicity in the Women's Health Initiative. Am J Kidney Dis. 2016 Feb; 67(2):198-208.
    View in: PubMed
    Score: 0.009
  161. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. PLoS One. 2015; 10(8):e0135674.
    View in: PubMed
    Score: 0.009
  162. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ. 2015 Feb 03; 350:h246.
    View in: PubMed
    Score: 0.009
  163. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.009
  164. Adiposity patterns and the risk for ESRD in postmenopausal women. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):241-50.
    View in: PubMed
    Score: 0.009
  165. Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
    View in: PubMed
    Score: 0.009
  166. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol. 2014 Aug 19; 64(7):660-8.
    View in: PubMed
    Score: 0.009
  167. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
    View in: PubMed
    Score: 0.008
  168. Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative. Stroke. 2014 Mar; 45(3):815-21.
    View in: PubMed
    Score: 0.008
  169. Prognostic stratification in older adults commencing dialysis. J Gerontol A Biol Sci Med Sci. 2014 Aug; 69(8):1033-9.
    View in: PubMed
    Score: 0.008
  170. Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):157-62.
    View in: PubMed
    Score: 0.008
  171. Coronary artery bypass graft type and outcomes in maintenance dialysis. J Cardiovasc Surg (Torino). 2015 Jun; 56(3):463-71.
    View in: PubMed
    Score: 0.008
  172. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013; 8(11):e78930.
    View in: PubMed
    Score: 0.008
  173. Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. Clin J Am Soc Nephrol. 2014 Jan; 9(1):82-91.
    View in: PubMed
    Score: 0.008
  174. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
    View in: PubMed
    Score: 0.008
  175. Multivessel coronary revascularization and outcomes in kidney transplant recipients. Transpl Int. 2013 Nov; 26(11):1080-7.
    View in: PubMed
    Score: 0.008
  176. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 Jun; 24(7):1151-8.
    View in: PubMed
    Score: 0.008
  177. Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation. 2013 Jun 15; 95(11):1338-45.
    View in: PubMed
    Score: 0.008
  178. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013 Mar; 65(3):753-63.
    View in: PubMed
    Score: 0.008
  179. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
    View in: PubMed
    Score: 0.008
  180. Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012 Dec; 125(12):1195-1204.e3.
    View in: PubMed
    Score: 0.007
  181. Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients. Clin Nephrol. 2012 Sep; 78(3):181-8.
    View in: PubMed
    Score: 0.007
  182. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
    View in: PubMed
    Score: 0.007
  183. Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Nephrol Dial Transplant. 2012 Jan; 27(1):429-34.
    View in: PubMed
    Score: 0.007
  184. Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data. Clin Pharmacol Ther. 2011 May; 89(5):674-82.
    View in: PubMed
    Score: 0.007
  185. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiol Drug Saf. 2009 Oct; 18(10):932-40.
    View in: PubMed
    Score: 0.006
  186. Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis. 2008 May; 51(5):811-8.
    View in: PubMed
    Score: 0.005
  187. No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients. Am J Nephrol. 2007; 27(4):390-6.
    View in: PubMed
    Score: 0.005
  188. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007 Apr 23; 167(8):840-6.
    View in: PubMed
    Score: 0.005
  189. Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post-CABG trial. Atherosclerosis. 2007 Aug; 193(2):414-20.
    View in: PubMed
    Score: 0.005
  190. Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int. 2006 Aug; 19(8):629-35.
    View in: PubMed
    Score: 0.005
  191. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol. 2006 Jun; 17(6):1688-94.
    View in: PubMed
    Score: 0.005
  192. Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg. 2006 Apr; 81(4):1385-92.
    View in: PubMed
    Score: 0.005
  193. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
    View in: PubMed
    Score: 0.005
  194. Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation. 2005 Sep 15; 80(5):582-9.
    View in: PubMed
    Score: 0.005
  195. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004 Jan; 13(1):11-9.
    View in: PubMed
    Score: 0.004
  196. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
    Score: 0.004
  197. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.